Clinical Trial Update: Procalcitonin Reveals Early Dehiscence in Pancreatic Surgery: the PREDIPS Study

View source ↗

Summary

A clinical trial update from the PREDIPS study suggests procalcitonin may reveal early dehiscence after pancreatic surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Pancreatic Cancer | Status: UNKNOWN